A phase 1, randomized, crossover trial to assess the effect of itraconazole on the pharmacokinetics of dordaviprone in healthy adults

Ähnliche Einträge

• Relative Bioavailability of Dordaviprone (ONC201) is Not Affected by Co‐Administration of the Proton‐Pump Inhibitor Rabeprazole
  von: Shamia L. Faison, et al.
  Veröffentlicht: (2024)
• Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate
  von: Tim Tippin, et al.
  Veröffentlicht: (2024)
• A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants
  von: Yohannes Teffera, et al.
  Veröffentlicht: (2025)
• Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial
  von: Alexander Hincker, et al.
  Veröffentlicht: (2024)
• Effects of rifampicin on the pharmacokinetics and safety of carotegrast methyl in healthy subjects: A randomized 2 × 2 crossover study
  von: Hiromitsu Imai, et al.
  Veröffentlicht: (2024)